Xianglin Wang
Chengdu, 610041, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Risk factors for poor response to autoimmune hepatitis: A systematic review and meta-analysis.
Journal: Clinics and research in hepatology and gastroenterology
Published: March 30, 2026
Predictors of recompensation in immunosuppressive therapy for biopsy-proven autoimmune hepatitis patients with decompensated cirrhosis.
Journal: Annals of hepatology
Published: November 03, 2025
Predictors of recompensation in immunosuppressive therapy for biopsy-proven autoimmune hepatitis patients with decompensated cirrhosis.
Journal: Annals of hepatology
Published: November 03, 2025
Genuine acute autoimmune hepatitis has better therapeutic response and prognosis.
Journal: Hepatology international
Published: September 17, 2025
Glycometabolic reprogramming of immune cells in autoimmune diseases.
Journal: Autoimmunity reviews
Published: March 28, 2025
Association of sarcopenia assessed by CT/MRI with treatment response and clinical outcomes in noncirrhotic primary biliary cholangitis patients.
Journal: European journal of radiology
Published: October 27, 2024
Letter: Fibrates may be safe and effective in patients with primary biliary cholangitis and decompensated cirrhosis.
Journal: Alimentary pharmacology & therapeutics
Published: May 01, 2024
Engaging natural regulatory myeloid cells to restrict T-cell hyperactivation-induced liver inflammation via extracellular vesicle-mediated purine metabolism regulation.
Journal: Theranostics
Published: April 17, 2024
Multi-omics approaches for drug-response characterization in primary biliary cholangitis and autoimmune hepatitis variant syndrome.
Journal: Journal of translational medicine
Published: October 18, 2023
Showing 1-9 of 9
Last Updated: 09/26/2026